187 related articles for article (PubMed ID: 18842348)
1. Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein.
Check JH; Dix E; Sansoucie L
Med Hypotheses; 2009 Jan; 72(1):87-90. PubMed ID: 18842348
[TBL] [Abstract][Full Text] [Related]
2. Mifepristone treatment improves length and quality of survival of mice with spontaneous lung cancer.
Check JH; Sansoucie L; Chern J; Dix E
Anticancer Res; 2010 Jan; 30(1):119-22. PubMed ID: 20150625
[TBL] [Abstract][Full Text] [Related]
3. Evidence that progesterone receptor antagonists may help in the treatment of a variety of cancers by locally suppressing natural killer cell activity.
Check JH; Sansoucie L; Chern J; Amadi N; Srivastava M; Larece K
Clin Exp Obstet Gynecol; 2007; 34(4):207-11. PubMed ID: 18225679
[TBL] [Abstract][Full Text] [Related]
4. The antiabortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity.
Szekeres-Bartho J; Par G; Dombay Gy; Smart YC; Volgyi Z
Cell Immunol; 1997 May; 177(2):194-9. PubMed ID: 9178647
[TBL] [Abstract][Full Text] [Related]
5. A progesterone-induced protein increases the synthesis of asymmetric antibodies.
Kelemen K; Bognar I; Paal M; Szekeres-Bartho J
Cell Immunol; 1996 Jan; 167(1):129-34. PubMed ID: 8548836
[TBL] [Abstract][Full Text] [Related]
6. PIBF: the double edged sword. Pregnancy and tumor.
Szekeres-Bartho J; Polgar B
Am J Reprod Immunol; 2010 Aug; 64(2):77-86. PubMed ID: 20367622
[TBL] [Abstract][Full Text] [Related]
7. Mifepristone treatment improves length and quality of survival of mice with spontaneous leukemia.
Check JH; Sansoucie L; Chern J; Amadi N; Katz Y
Anticancer Res; 2009 Aug; 29(8):2977-80. PubMed ID: 19661303
[TBL] [Abstract][Full Text] [Related]
8. Therapy Aimed to Suppress the Production of the Immunosuppressive Protein Progesterone Induced Blocking Factor (PIBF) May Provide Palliation and/or Increased Longevity for Patients With a Variety of Different Advanced Cancers - A Review.
Check JH; Check D
Anticancer Res; 2019 Jul; 39(7):3365-3372. PubMed ID: 31262857
[TBL] [Abstract][Full Text] [Related]
9. Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone.
Srivastava MD; Thomas A; Srivastava BI; Check JH
Leuk Lymphoma; 2007 Aug; 48(8):1610-7. PubMed ID: 17701593
[TBL] [Abstract][Full Text] [Related]
10. A model for potential tumor immunotherapy based on knowledge of immune mechanisms responsible for spontaneous abortion.
Check JH; Nazari P; Goldberg J; Yuen W; Angotti D
Med Hypotheses; 2001 Sep; 57(3):337-43. PubMed ID: 11516226
[TBL] [Abstract][Full Text] [Related]
11. Progesterone-induced blocking factor is hormonally regulated in human astrocytoma cells, and increases their growth through the IL-4R/JAK1/STAT6 pathway.
González-Arenas A; Valadez-Cosmes P; Jiménez-Arellano C; López-Sánchez M; Camacho-Arroyo I
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():463-70. PubMed ID: 25218441
[TBL] [Abstract][Full Text] [Related]
12. Mifepristone may halt progression of extensively metastatic human adenocarcinoma of the colon - case report.
Check JH; Dix E; Sansoucie L; Check D
Anticancer Res; 2009 May; 29(5):1611-3. PubMed ID: 19443374
[TBL] [Abstract][Full Text] [Related]
13. Human trophoblast cells express the immunomodulator progesterone-induced blocking factor.
Anderle C; Hammer A; Polgár B; Hartmann M; Wintersteiger R; Blaschitz A; Dohr G; Desoye G; Szekeres-Barthó J; Sedlmayr P
J Reprod Immunol; 2008 Oct; 79(1):26-36. PubMed ID: 18817979
[TBL] [Abstract][Full Text] [Related]
14. PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome.
Lachmann M; Gelbmann D; Kálmán E; Polgár B; Buschle M; Von Gabain A; Szekeres-Barthó J; Nagy E
Int J Cancer; 2004 Oct; 112(1):51-60. PubMed ID: 15305375
[TBL] [Abstract][Full Text] [Related]
15. A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation.
Check JH; Check DL
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830233
[TBL] [Abstract][Full Text] [Related]
16. Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome.
Polgár B; Nagy E; Mikó E; Varga P; Szekeres-Barthó J
Biol Reprod; 2004 Nov; 71(5):1699-705. PubMed ID: 15269099
[TBL] [Abstract][Full Text] [Related]
17. Mifepristone causing complete remission of rapidly advancing leukemia with measurement of progesterone-induced blocking factor.
Check JH; Check D; Cohen R; Sarumi M
Anticancer Res; 2014 May; 34(5):2413-6. PubMed ID: 24778052
[TBL] [Abstract][Full Text] [Related]
18. The progesterone receptor antagonist mifepristone does not lower serum progesterone induced blocking factor (PIBF) in the presence of progesterone.
Check JH; DiAntonio G; DiAntonio A; Duroseau M
Clin Exp Obstet Gynecol; 2016; 43(2):189-91. PubMed ID: 27132407
[TBL] [Abstract][Full Text] [Related]
19. Changes in progesterone-induced-blocking-factor expression rates following mifepristone administration in termination of pregnancy at 5 to 8 weeks.
Salomon LJ; Rozenberg P; Szekeres-Bartho J; Malagrida L; Giudicelli Y; Ville Y
J Matern Fetal Neonatal Med; 2005 May; 17(5):353-6. PubMed ID: 16147850
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of a novel monoclonal antibody against progesterone-induced blocking factor (PIBF).
Ivanova-Todorova E; Kyurkchiev DS; Nalbanski A; Timeva T; Shterev A; Kyurkchiev SD
J Reprod Immunol; 2008 Jul; 78(2):94-101. PubMed ID: 18243332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]